CRELOSIDENIB

UNII:	A4DU555RMD
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₈H₃₆N₆O₃
Preferred Substance Name:	CRELOSIDENIB
InChIKey:	AFGYODUJVVOZAX-CYFREDJKSA-N
GSRS Full Record:	A4DU555RMD i

2230263-60-0
2H-Pyrimido[4,5-d][1,3]oxazin-2-one, 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]ethyl]phenyl]ethyl]amino]-1-ethyl-1,4-dihydro-
7-(((S)-1-(4-((S)-1-(4-acryloylpiperazin-1-yl)-2-cyclopropylethyl)phenyl)ethyl)amino)-1-ethyl-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-one bis(2,5-dihdroxybenzoate)
7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-(4-prop-2-enoylpiperazin-1-yl)ethyl]phenyl]ethyl]amino]-1-ethyl-4H-pyrimido[4,5-d][1,3]oxazin-2-one
CRELOSIDENIB [USAN]
Crelosidenib
LSN-3856920
LSN3856920
LY 3410738 [WHO-DD]
LY-3410738
LY3410738
crelosidenib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CRELOSIDENIB

Synonyms and Mappings

Resources